CCND1 and esophageal squamous cell carcinoma: The Epstein–Barr virus ED-L2, an early lytic cycle promoter that targets the cyclin D1 in a transgenic mouse model leading to dysplasia and premalignant condition in the esophagus is the most commonly used method to induce esophageal squamous cell carcinoma [20,21].